1. Sanofi (France)
2. Pfizer Inc. (US)
3. GlaxoSmithKline plc (UK)
4. Novartis AG (Switzerland)
5. Bayer AG (Germany)
6. Eli Lilly and Company (US)
7. Merck & Co. Inc. (US)
8. AstraZeneca
Published | Pages | Publisher | Report code |
---|---|---|---|
Apr 2023 | 350 | Renub Research | ASDR-620378 |
1. Sanofi (France)
2. Pfizer Inc. (US)
3. GlaxoSmithKline plc (UK)
4. Novartis AG (Switzerland)
5. Bayer AG (Germany)
6. Eli Lilly and Company (US)
7. Merck & Co. Inc. (US)
8. AstraZeneca